million baht or 16.6% because at the end of the Q1-2023, the Company received share subscription from the exercise of warrants in the amount of 100,248,383 shares at a price of 2 baht per share with a par
to December 31, 2018. The significant changes in assets comprised of: Increase in cash and cash equivalents of THB 985.00 million, causing from - proceeds from capital increase in ordinary shares net
: Increase in cash and cash equivalents of THB 985.00 million, causing from - proceeds from capital increase in ordinary shares net with payments for share issue costs of THB 1,675.28 million.; - net cash
expenses 6.73 0.30% 4.88 0.27% 1.85 37.91 Share of losses from associates 0.27 0.01% 0.00 0.00% 0.27 100.00 Income tax 20.77 0.94% 26.23 1.43% -5.46 -20.82 Net profit 43.95 1.98% 113.72 6.21% -69.77 -61.35
Conversion Plan of the Company of which a plan for allocation and offering of the newly issued ordinary shares of the Company according to the Debt to Equity Conversion Scheme, was a part thereof. This would
Wattanapat Samui Hospital Capital Structure : The registered fund 160 Million Baht; subdivided into 1,600,000 shares Par Value 100 Baht Payment fee 0 Baht Shareholder Structure : Company Limited will be hold a
Wattanapat Samui Hospital Capital Structure : The registered fund 160 Million Baht; subdivided into 1,600,000 shares Par Value 100 Baht Payment fee 0 Baht Shareholder Structure : Company Limited will be hold a
from sale of investment in securities (2.36) (0.76) (1.61) -212.75% Shares of profit (loss) in of associates (2.66) (28.93) 26.27 90.80% Financing Cost (42.35) (53.53) 11.18 20.88% (80.36) (595.34
premium on shares from the issuance and offering the new ordinary shares by Private Placement and the exercise of ECF-W2 No.2/6 and No.3/6 with the exercise price Baht 3 per share. Kindly be informed
84.20 376.72 (292.52) -347.42% 1,482.63 1,825.67 (343.03) -23.14% SHAREHOLDERS' EQUITY Issued and paid-up share capital 1,316.25 1,316.25 - 0.00% Premium on ordinary shares 264.33 264.33 - 0.00% Surplus